title: Role of 100-kDa cytosolic PLA2 in ACh-induced contraction of cat esophageal circular muscle.
abstract: We have shown that acetylcholine (ACh)-induced contraction of esophageal circular muscle cells is mediated by activation of protein kinase C (PKC). We now examine the role of phospholipase A2 (PLA2). ACh increases [3H]arachidonic acid release in esophageal but not in lower esophageal sphincter (LES) muscle. In addition, ACh-induced contraction of esophageal but not of LES cells was reduced by the PLA2 antagonist dimethyleicosadienoic acid and by antiserum to a 100-kDa cytosolic PLA2 (cPLA2). These data suggest that the 100-kDa cPLA2 plays a role in ACh-induced contraction of esophageal but not of LES muscle. In esophageal cells, arachidonic acid produced by PLA2 caused little contraction by itself but potentiated contraction induced by the PKC agonist diacylglycerol (DAG). The free fatty acids linoleic acid and linolenic acid also potentiated DAG-induced contraction. Indomethacin and nordihydroguaiaretic acid had no effect on arachidonic acid-induced potentiation of DAG. The potentiation of DAG-induced contraction by arachidonic acid was inhibited by the PKC inhibitor H-7, but it was not affected by the calmodulin inhibitor CGS-9343B. We conclude that a 100-kDa cPLA2 participates in ACh-induced esophageal contraction by producing arachidonic acid and potentiating DAG-induced activation of a PKC-dependent pathway.
authors.affiliation: Rhode Island Hospital, Providence 02903.
authors.forename: U D
authors.initials: UD
authors.lastname: Sohn
authors.forename: D K
authors.initials: DK
authors.lastname: Kim
authors.forename: J V
authors.initials: JV
authors.lastname: Bonventre
authors.forename: J
authors.initials: J
authors.lastname: Behar
authors.forename: P
authors.initials: P
authors.lastname: Biancani
mesh_terms: D000109:Acetylcholine / Q000494:pharmacology*; D000818:Animals; D016718:Arachidonic Acid / Q000037:antagonists & inhibitors / Q000494:pharmacology; D002415:Cats; D003600:Cytosol / Q000201:enzymology*; D004075:Diglycerides / Q000494:pharmacology; D004357:Drug Synergism; D004943:Esophagogastric Junction / Q000166:cytology / Q000187:drug effects / Q000502:physiology; D004947:Esophagus / Q000166:cytology / Q000187:drug effects* / Q000502:physiology; D005260:Female; D008297:Male; D008970:Molecular Weight; D009119:Muscle Contraction / Q000502:physiology*; D009130:Muscle, Smooth / Q000166:cytology / Q000187:drug effects* / Q000502:physiology; D010741:Phospholipases A / Q000378:metabolism / Q000502:physiology*; D054467:Phospholipases A2; D011233:Precipitin Tests
chemical_list: D004075:Diglycerides; D016718:Arachidonic Acid; D010741:Phospholipases A; D054467:Phospholipases A2; D000109:Acetylcholine